Elevance Health Inc 's Revenue in the fiscal year 2025 $ 199,125.00 millions
Elevance Health Inc 's Revenue in the fiscal year 2024 $ 177,011.00 millions
Elevance Health Inc 's Revenue in the fiscal year 2023 $ 171,340.00 millions
Elevance Health Inc 's Revenue in the fiscal year 2022 $ 156,595.00 millions
Elevance Health Inc 's Revenue in the fiscal year 2021 $ 138,639.00 millions
ELV Revenue second quarter 2026 Y/Y Growth Comment
Elevance Health Inc reported Revenue growth of 1.4% year on year in the second quarter 2026, to $ 50,474.00 millions, this is lower than Elevance Health Inc 's recent average Revenue growth of 7.49%.
Looking into second quarter 2026 results within Accident & Health Insurance industry 12 other companies have achieved higher Revenue growth. While Elevance Health Inc ' s Revenue increase of 1.4% ranks overall at the positon no. 2283 in the second quarter 2026.
ELV Revenue ( Y/Y Growth %)
2026
2025
2024
2023
4th Quarter
December
-
9.47 %
6.55 %
6.81 %
3rd Quarter
September
-
12.43 %
5.27 %
7.29 %
2nd Quarter
June
1.4 %
13.42 %
0.49 %
13.05 %
1st Quarter
March
2.64 %
14.83 %
0.96 %
10.7 %
FY
-
12.49 %
3.31 %
-
Financial Statements
Elevance Health Inc 's second quarter 2026 Revenue
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Elevance Health Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
23.48 %
1.78 %
-20.73 %
(Dec 31 2009)
ELV's II. Quarter Q/Q Revenue Comment
Elevance Health Inc achieved in the II. Quarter 2026 below company average Revenue growth of 0.58% quarter on quarter, to $ 50,474.00 millions.
Within Accident & Health Insurance industry 6 other companies have achieved higher Revenue quarter on quarter growth. While Elevance Health Inc 's Revenue growth quarter on quarter, overall rank is 1688.
Elevance Health Inc achieved in the II. Quarter 2026 below company average Revenue growth of 0.58% quarter on quarter, to $ 50,474.00 millions.
Within Accident & Health Insurance industry 6 other companies have achieved higher Revenue quarter on quarter growth. While Elevance Health Inc 's Revenue growth quarter on quarter, overall rank is 1688.
Elevance Health Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 201,113.00
$ 200,415.00
$ 199,125.00
$ 194,820.00
$ 189,215.00
Y / Y Revenue Growth (TTM)
6.29 %
9.32 %
12.49 %
11.83 %
10.03 %
Year on Year Revenue Growth Overall
Ranking
# 1504
# 1853
# 1354
# 1246
# 1084
Seqeuential Revenue Change (TTM)
0.35 %
0.65 %
2.21 %
2.96 %
3.21 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2283
# 2207
# 1943
# 84
# 1847
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Elevance Health Inc 's cumulative twelve months Revenue were $ 201,113 millions, company would post below average annual Revenue growth of 3.21% year on year, if the fiscal year would end at Jun 30 2026. A slow-down in the Elevance Health Inc 's Revenue growth from the 50181% growth in Mar 31 2026.
In the Financial sector 380 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1504, from total ranking in previous quarter at 1853.
With the quarterly Revenue reported in the Jun 30 2026 period, Elevance Health Inc 's cumulative twelve months Revenue were $ 201,113 millions, company would post below average annual Revenue growth of -9.83% year on year, if the fiscal year would end at Jun 30 2026. A slow-down in the Elevance Health Inc 's Revenue growth from the 50181% growth in Mar 31 2026.
In the Financial sector 380 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1504, from total ranking in previous quarter at 1853.
About Elevance Health Inc Revenue Growth Rates (ELV), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.